TLR4 and familial pancreatic carcinoma: More recently, we described in advanced stage pancreatic cancers overexpressed TLR2, TLR4, TLR7, and TLR9 predominantly in tumor cells rather than tumor-infiltrating immune cells, making TLR inhibition strategies in this tumor even more interesting.